Table 2.
Quality assessment of the different included studies according to the Newcastle-Ottawa Scale [14].
| Study | Selectiona | Outcomeb | Score |
|---|---|---|---|
| Iqbal 2001 [22] | ** | *** | 5/6 |
| Wang 2004 [23] | ** | *** | 5/6 |
| Channa 2005 [28] | ** | *** | 5/6 |
| Rajasekar 2006 [29] | ** | * | 3/6 |
| Yeh 2007 [31] | ** | * | 3/6 |
| Tu 2011 [12] | ** | *** | 5/6 |
| Tan 2013 [19] | *** | *** | 6/6 |
| Krishnan 2013 [30] | ** | * | 3/6 |
| Cioffi 2014 [32] | ** | ** | 4/6 |
| Ekwunife 2015 [24] | ** | ** | 4/6 |
| Groeschl 2016 [25] | ** | * | 3/6 |
| Saha 2016 [10] | ** | *** | 5/6 |
| Dhamodharan 2018 [20] | *** | *** | 6/6 |
| Dhir 2019 [26] | ** | * | 3/6 |
| Chitrambalam 2019 [21] | *** | *** | 6/6 |
| Minh 2019 [11] | ** | ** | 4/6 |
| Mogahed 2020 [27] | ** | ** | 4/6 |
a The maximum score possible was 3 stars.
b Criteria used to assess outcome were evaluation of recurrent or residual liver abscess in the follow-up. The maximum score possible was 3 stars.